TGFB1 and liver dysplastic nodule: In 2019, Ravindran et al. found that, under high glucose conditions, RPTC-derived MVs activated key signaling pathways (mTOR, ERK, ER, TGF-β, and EMT) in naïve RPTCs, thus inducing renal cell injury and DN development (38).